1. Melatonin alleviates PM 2.5 -triggered macrophage M1 polarization and atherosclerosis via regulating NOX2-mediated oxidative stress homeostasis.
- Author
-
Liu J, Sun Q, Sun M, Lin L, Ren X, Li T, Xu Q, Sun Z, and Duan J
- Subjects
- Animals, Homeostasis, Kelch-Like ECH-Associated Protein 1 metabolism, Macrophages metabolism, Mice, NADPH Oxidase 2 genetics, NADPH Oxidase 2 metabolism, NF-E2-Related Factor 2 metabolism, Oxidative Stress, Particulate Matter metabolism, Particulate Matter toxicity, Atherosclerosis metabolism, Melatonin metabolism, Melatonin pharmacology
- Abstract
It is reported that oxidative stress homeostasis was involved in PM
2.5 -induced foam cell formation and progression of atherosclerosis, but the exact molecular mechanism is still unclear. Melatonin is an effective antioxidant that could reverse the cardiopulmonary injury. The main purpose of this study is to investigate the latent mechanism of PM2.5 -triggered atherosclerosis development and the protective role of melatonin administration. Vascular Doppler ultrasound showed that PM2.5 exposure reduced aortic elasticity in ApoE-/- mice. Meanwhile, blood biochemical and pathological analysis demonstrated that PM2.5 exposure caused dyslipidemia, elicited oxidative damage of aorta and was accompanied by an increase in atherosclerotic plaque area; while the melatonin administration could effectively alleviate PM2.5 -induced macrophage M1 polarization and atherosclerosis in mice. Further investigation verified that NADPH oxidase 2 (NOX2) and mitochondria are two prominent sources of PM2.5 -induced ROS production in vascular macrophages. Whereas, the combined use of two ROS-specific inhibitors and adopted with melatonin markedly rescued PM2.5 -triggered macrophage M1 polarization and foam cell formation by inhibiting NOX2-mediated crosstalk of Keap1/Nrf2/NF-κB and TLR4/TRAF6/NF-κB signaling pathways. Our results demonstrated that NOX2-mediated oxidative stress homeostasis is critical for PM2.5 -induced atherosclerosis and melatonin might be a potential treatment for air pollution-related cardiovascular diseases., (Copyright © 2022 Elsevier Inc. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF